Chemours director Mather acquires 2,118 stock units
The deferred units are payable in the first month after the director’s service ends, and each represents the economic equivalent of one common share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chemours Co director Courtney Mather acquired 2,118 deferred stock units on September 30, 2026, at a reported price of $13.57 per share. Each unit is the economic equivalent of one share of Chemours common stock and becomes payable in the first month following Mather’s termination of service as a director. Her reported resulting position was 11,147.0456 units, including deferred stock units and dividend equivalent units.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units F1, F2 | 2,118 | $13.57 | $29K |
Footnotes (2)
- F1. Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the first month following the Reporting Person's termination of service as a director.
- F2. Includes deferred stock units and dividend equivalent units.
Key Figures
Key Terms
deferred stock units financial
dividend equivalent units financial
termination of service financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many deferred stock units did CC director Courtney Mather acquire?
AI-generated analysis. How Rhea-AI works. Not financial advice.